12:13 PM EST - Lorus Therapeutics Inc. : reported Tuesday a second-quarter loss of $2.8 million, reduced from a year-earlier loss of $3.1 million. The loss amounted to 1 cent per share in both periods. Research and development expenses in the three months ended Nov. 30, 2007 increased to $1.2 million from $1.1 million in the same period last year. The company has yet to record significant revenues from sales. Lorus Therapeutics Inc.
shares T.LOR are trading off 1 cent at $0.18.
